Grant Support

Current Grant Support

NIH/NIDDK (R01 DK109692), “Early childhood diet, growth, gut microbiome and lung health in cystic fibrosis” (2016-2021).  Farrell, Co-Investigator

NIH/NIDDK (R01 DK072126), “Newborn screening, malnutrition and lung disease in children with cystic fibrosis” (2005-2017).  Farrell, Co-Investigator

Cystic Fibrosis Foundation Therapeutics (Bridge Funding), “Early childhood diet, growth, gut microbiome and lung health in cystic fibrosis” (2016).  Farrell, Co-Investigator

Legacy of Angels Foundation, “A prospective study on newborn screening for cystic fibrosis using a novel IRT/next generation sequencing method” (2014-2016).  Farrell, Co-PI

Cystic Fibrosis Foundation Therapeutics, “Feeding infants right...from the start (FIRST) study” (2014-2016).  Farrell, Co-Investigator


Completed Grants

NIH/NIDDK (R56 DK109692), “Early childhood diet, growth, gut microbiome and lung health in cystic fibrosis” (2015-2016).  Farrell, Co-Investigator

Legacy of Angels Foundation, “Improving IRT/DNA newborn screening for cystic fibrosis to reduce false positives by a new molecular strategy” (2012-2015).  Farrell, Co-PI

NIH/Office of the Director (DP2 OD007031), “Integration of genomics with genetics – molecular phenotypes for CF lung disease” (2010-2015).  Farrell, Advisor

Legacy of Angels Foundation, “Quality improvement in cystic fibrosis newborn screening: improving follow-up and outcomes with tools for facilitative interactive communication” (2012-2014).  Farrell, Co-Investigator

Legacy of Angels Foundation, “Quality improvement in cystic fibrosis newborn screening: addressing the sweat test QNS problem with a novel method” (2012-2014).  Farrell, Co-Investigator

NIH/NHLBI (R21 HL102523), “IL-1 family gene polymorphisms and susceptibility to P. aeruginosa in CF patients” (2010-2012).  Farrell, Advisor

NIH/NIDDK (R01 DK034108), “Pulmonary benefits of cystic fibrosis neonatal screening” (1985-2012).  Farrell, PI

NIH/NIDDK (R01 DK034108-23S1), “Pulmonary benefits of cystic fibrosis neonatal screening” (2010-2011).  Farrell, PI

NIH/NHLBI & Medical College of Wisconsin (RC1 HL100819), “A rapid-throughput feedback intervention for population-scale communication quality assurance projects” (2010-2011).  Farrell, Co-Investigator

NIH/NHLBI (R01 HL086691), “Improvement of communication process and outcomes after newborn genetic screening” (2008-2011).  Farrell, Advisor

NIH/NHGRI (R21 HG004252), “Developing a family-centered approach for genetic counseling: a new paradigm” (2008-2011).  Farrell, Co-Investigator

NIH/NIDDK (R01 DK072126), “Malnutrition and lung disease in cystic fibrosis” (2006-2011). Farrell, Co-Investigator

Cystic Fibrosis Foundation, “Pulmonary benefits of cystic fibrosis neonatal screening: psychosocial outcomes” (2006-2011).  Farrell, PI

Worldwide Universities Network, “The ancient origin of cystic fibrosis” (2007-2008).  Farrell, PI

NIH/NHLBI (K01 HL072530), “Quality of communication after newborn genetic screening” (2003-2008). Farrell, Advisor

NIH/NCRR (C06 RR020102), “Extramural facilities improvement program” (2004).  Farrell, PI

NIH/NCRR (M01 RR03186), “General clinical research center - University of Wisconsin” (1994-2004). Farrell, PI

Howard Hughes Medical Institute, “UW/HHMI carrier development program in molecular mechanisms of disease” (1996-2003).  Farrell, PI

The Robert Wood Johnson Foundation, “Health professions partnership initiative” (1996-2001). Farrell, PI

NIH/NHLBI (P50 HL046478), "SCOR: lung biology and diseases in infants and children - pathology of bronchopulmonary dysplasia" (1991-1996). Farrell, PI

Mead John Nutritionals, "Cystic fibrosis neonatal screening" (1988-1991). Farrell, PI

Cystic Fibrosis Foundation, "Supplement of assessment of the benefits and risks of neonatal screening for cystic fibrosis" (1988-1990). Farrell, PI

NIH/NHLBI (R0I HL038149), "Risk factors in bronchopulmonary dysplasia" (1987-1988). Farrell, Co-Investigator

Mead Johnson Nutritional Group, "Nutritional benefits of cystic fibrosis screening" (1985-1987). Farrell, PI

National Institutes of Health (P50 HL27358), "SCOR: nutrition and metabolism in infant lung disease" (1981-1986). Farrell, PI

NIH/Fogarty Center (F06 TW00881), “Fogarty senior international fellowship” for research at College de France on fetal lung development in the diabetic pregnancy (1985). Farrell, PI

Cystic Fibrosis Foundation (A001 5-01), "Benefits and risks of cystic fibrosis neonatal screening" (Voluntarily terminated in 1985). Farrell, PI

American Lung Association, "Pediatric pulmonary fellowships- institutional training grant" (1982-1985). Farrell, PI

Mead Johnson, Inc., "Choline nutrition in low birthweight infants" (1984). Farrell, PI

Cystic Fibrosis Foundation, "Correction of linoleic acid deficiency in cystic fibrosis" (1979-1982). Farrell, PI

Juvenile Diabetes Foundation, "Mechanisms of abnormal fetal and neonatal lung metabolism in pregnancies complicated by diabetes" (1979-1981). Farrell, Co- Investigator

NIH/NICHD (HD011429), "Fetal lung development in the diabetic pregnancy" (1978-1981). Farrell, PI

Cystic Fibrosis Foundation, "Care, teaching, and research center grant" (1977-1981). Farrell, PI

National Foundation-March of Dimes, "Substrate-mediated control of lung phosphatidylcholine metabolism" (1977-1980). Farrell, PI

Organon Pharmaceuticals, Inc., "Assessment of digestants in cystic fibrosis" (1979). Farrell, PI

Cystic Fibrosis Foundation, “Essential fatty acids in cystic fibrosis as related to vitamin E deficiency" (1977-1979). Farrell, PI

Cystic Fibrosis Foundation, "Effects of vitamin E deficiency in man" (1973-1975). Farrell, PI